Panacea Biotec Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 117.20 | 73.99 | 111.75 |
| Operating Expense | 115.27 | 86.47 | 93.04 |
| Net Profit | -6.70 | -12.39 | 9.65 |
| Net Profit Margin | -5.72 | -16.75 | 8.64 |
| Earning Per Share | -1.09 | -2.02 | 1.58 |
| EBIDTA | 4.07 | -2.84 | 18.71 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 117.20 |
| Operating Expense | 115.27 |
| Net Profit | -6.70 |
| Net Profit Margin | -5.72 |
| Earning Per Share | -1.09 |
| EBIDTA | 4.07 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 309.86 | 359.60 | 257.07 |
| Operating Expenses Annual | 316.79 | 345.44 | 319.69 |
| Operating Profit Annual | 9.69 | 39.07 | -28.19 |
| Interest Annual | 15.46 | 13.78 | 10.06 |
| Depreciation | 20.22 | 21.07 | 24.48 |
| Net Profit Annual | -15.23 | 3.55 | -87.54 |
| Tax Annual | -10.83 | 0.66 | 24.79 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 309.86 |
| Operating Expenses Annual | 316.79 |
| Operating Profit Annual | 9.69 |
| Interest Annual | 15.46 |
| Depreciation | 20.22 |
| Net Profit Annual | -15.23 |
| Tax Annual | -10.83 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 5.09 | 6.01 | 5.33 |
| Cash Flow from Operations | 3.94 | 33.07 | -10.74 |
| Cash Flow from Investing | -60.60 | -46.80 | 2.41 |
| Cash Flow from Financing | 90.07 | 12.82 | 9.01 |
| Cash Flow at the End | 38.50 | 5.09 | 6.01 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 5.09 |
| Cash Flow from Operations | 3.94 |
| Cash Flow from Investing | -60.60 |
| Cash Flow from Financing | 90.07 |
| Cash Flow at the End | 38.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 3.13 | 10.86 | -10.97 |
| PBIT Margin (%) | -3.42 | 5 | -20.50 |
| PBT Margin (%) | -3.20 | 4.64 | -18.46 |
| Net PROFIT Margin (%) | -4.92 | 0.99 | -34.05 |
| Return On Networth / Equity (%) | TBA | 0.86 | TBA |
| Return On Networth /Employed (%) | TBA | 3.26 | TBA |
| Return On Assets (%) | -2.90 | 0.76 | -18.05 |
| Total Debt / Equity (X) | 0.52 | 0.32 | 0.24 |
| Asset Turnover Ratio (%) | 0.59 | 0.77 | 0.53 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 3.13 |
| PBIT Margin (%) | -3.42 |
| PBT Margin (%) | -3.20 |
| Net PROFIT Margin (%) | -4.92 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -2.90 |
| Total Debt / Equity (X) | 0.52 |
| Asset Turnover Ratio (%) | 0.59 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 379.70 | 383.00 | 396.74 |
| Total Current Assets Annual | 293.73 | 183.49 | 199.13 |
| Non Current Assets Annual | 575.74 | 570.30 | 518.77 |
| Total Shareholders Funds Annual | 313.97 | 329.14 | 325.65 |
| Total Assets Annual | 869.47 | 753.79 | 723.90 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 379.70 |
| Total Current Assets Annual | 293.73 |
| Non Current Assets Annual | 575.74 |
| Total Shareholders Funds Annual | 313.97 |
| Total Assets Annual | 869.47 |
EPS (INR)
Expected
0.66
Reported
0.66
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
